Tuesday, October 27, 2020
Home Coronavirus COVID-19: lung function and proinsulin c peptide

COVID-19: lung function and proinsulin c peptide

The biggest risk the COVID-19 carries in terms of mortality is the decrease in the lungs’ overall functionality. These functions may already be damaged due to other reasons as well, for example, smokers, people with diabetes mellitus, COPD and of course people with Asthma. Also, it is an interesting consequence of Type 1 diabetes, that the pancreas ceases production of C Peptide. Lung efficiency is lower for people who have diabetes, however in case the patient goes through a pancreas transplant, the production of c peptide is restored, and lung efficiency is drastically increased.

The integrity of the central nervous system also heavily correlates with the functioning of the lungs, as it is responsible for the Heart Rate Variability (HRV). When damaged, it signals vertigo and impairing functions in the sympathetic and parasympathetic nervous systems. Of course, the HRV is lower as a consequence for smokers, and people living with diabetes mellitus, and COPD.

Now comes the important part: Clinical trials with placebo have proven (one example in the links below), that the replacement of proinsulin c peptide raises rapidly the HRV of people with type 1 diabetes mellitus, and strengthens the functioning of their autonomic nervous system. (A study carried out in 1996 on c-peptide also states, that the damage to the autonom immune system may also be the main reason for people developing COPD.).

Now I am asking everyone to think: How come, that more than 20 years now, there is no generally approved proinsulin c peptide supplements or replacement for those in need. Because it is clear that the c peptide levels of the people living with these conditions is lowered. These are all risk factors for COVID-19 to turn more severe.


https://pubmed.ncbi.nlm.nih.gov/8781764/

https://www.reuters.com/article/us-health-coronavirus-breathing/patients-with-breathing-lung-problems-at-highest-risk-with-covid-19-study-idUSKBN2153ED

https://www.medrxiv.org/content/10.1101/2020.03.15.20035360v1

https://pubmed.ncbi.nlm.nih.gov/17353775/?dopt=Abstract

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621220/

https://pubmed.ncbi.nlm.nih.gov/29608603/

https://care.diabetesjournals.org/content/37/2/389

https://pubmed.ncbi.nlm.nih.gov/14747296/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015664/

Népszerű írások

Is Remdesivir a good choice?

Remdesivir was bought up by the Americans. There are no more for others, supposedly Remdesivir will available only for the US at...

COVID-19: Restoring endogenous nitric oxide (NO) related homeostasis may be an effective and natural way to decrease replication of COVID-19

NO seems to inhibit the replication cycle of severe acute respiratory coronavirus. It is expected that this can be exploited in...

COVID-19: Potential risks of aluminum adjuvant of vaccines for the central nervous system and the possible beneficial effect of central proinsulin c peptide

According to recent epidemiologic data, BCG vaccination may provide some protection against COVID-19 infection and may reduce the severity of it. (1)...

Gábor Varga talks about the future of coronavirus

https://vimeo.com/434322213 Many people have questions about the coronavirus epidemic. What will happen next? What to do and...

COVID19: Strange, similar symptoms, although tests are not always accurate

https://vimeo.com/434321760 Researchers around the world have also acknowledged that a negative COVID 19 test result does not...

A honlap további használatához a sütik használatát el kell fogadni. További információ

A süti beállítások ennél a honlapnál engedélyezett a legjobb felhasználói élmény érdekében. Amennyiben a beállítás változtatása nélkül kerül sor a honlap használatára, vagy az "Elfogadás" gombra történik kattintás, azzal a felhasználó elfogadja a sütik használatát.

Bezárás